TRIM33 and cancer: Somatic gene mutations and loss of heterozygosity of TIF1-γ, one of the major target autoantigens of CAM-associated MSAs (42), were found more frequently in cancer tissues of CAM patients with anti-TIF1-γ antibody than in those of non-CAM patients without anti-TIF1-γ antibody (43).